Pharma-Bio Serv (PBSV) Net Margin (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Net Margin came in at 8.62% in Q2 2026, up 467.0% on a YoY basis from 1.52% in Q2 2025, and up 502.01% quarter-over-quarter from 1.43% in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Net Margin (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Net Margin for 16 consecutive years, with 8.62% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 467.0% year-over-year to 8.62%; the trailing twelve-month figure through Apr 2026 stood at 0.57% (up 253.0% YoY), and the FY2025 full-year result was 1.12%, up 706.0% from the prior year.
- Net Margin rose to 8.62% in Q2 2026 per PBSV's latest filing, from 1.43% in the prior quarter.
- Across five years, Net Margin topped out at 11.5% in Q3 2023 and bottomed at 12.79% in Q3 2024.
- Historically, Net Margin has averaged 1.15% across 5 years, with a median of 2.58% in 2026.
- The widest YoY moves for Net Margin: up 9079 bps in 2022, down 3958 bps in 2022.
- Over 5 years, Net Margin stood at 3.74% in 2022, then plunged by 135 bps to 1.31% in 2023, then soared by 153 bps to 0.69% in 2024, then sank by 101 bps to 0.0% in 2025, then surged by 181759 bps to 8.62% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 8.62%, 1.43%, and 0.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 12.76% |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 31.13% |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 16.44% |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 8.37% |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 7.07% |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 10.85% |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 9.61% |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 5.82% |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 17.37% |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 8.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 8.62% |
| Jan 31, 2026 | 1.43% |
| Oct 31, 2025 | 0.00% |
| Jul 31, 2025 | -10.89% |
| Apr 30, 2025 | 3.95% |
| Jan 31, 2025 | 0.35% |
| Oct 31, 2024 | 0.69% |
| Jul 31, 2024 | -12.79% |
| Apr 30, 2024 | -8.99% |
| Jan 31, 2024 | -11.37% |
| Oct 31, 2023 | -1.31% |
| Jul 31, 2023 | 11.50% |
| Apr 30, 2023 | 8.87% |
| Jan 31, 2023 | 10.06% |
| Oct 31, 2022 | 3.74% |
| Jul 31, 2022 | 6.03% |
| Apr 30, 2022 | 4.83% |
| Jan 31, 2022 | 6.08% |
| Oct 31, 2021 | -87.05% |
| Jul 31, 2021 | 45.61% |